##gff-version 3
##sequence-region Q7Z434 1 540
Q7Z434	UniProtKB	Chain	1	540	.	.	.	ID=PRO_0000144096;Note=Mitochondrial antiviral-signaling protein	
Q7Z434	UniProtKB	Topological domain	1	513	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q7Z434	UniProtKB	Transmembrane	514	534	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q7Z434	UniProtKB	Topological domain	535	540	.	.	.	Note=Mitochondrial intermembrane;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q7Z434	UniProtKB	Domain	10	77	.	.	.	Note=CARD	
Q7Z434	UniProtKB	Region	10	77	.	.	.	Note=Required for interaction with NLRX1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18200010;Dbxref=PMID:18200010	
Q7Z434	UniProtKB	Region	95	297	.	.	.	Note=Disordered;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite	
Q7Z434	UniProtKB	Region	143	147	.	.	.	Note=Interaction with TRAF2;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16153868;Dbxref=PMID:16153868	
Q7Z434	UniProtKB	Region	153	158	.	.	.	Note=Interaction with TRAF6	
Q7Z434	UniProtKB	Region	314	358	.	.	.	Note=Disordered;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite	
Q7Z434	UniProtKB	Region	373	419	.	.	.	Note=Disordered;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite	
Q7Z434	UniProtKB	Region	455	460	.	.	.	Note=Interaction with TRAF6	
Q7Z434	UniProtKB	Region	476	507	.	.	.	Note=Disordered;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite	
Q7Z434	UniProtKB	Motif	439	442	.	.	.	Note=pLxIS motif;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25636800;Dbxref=PMID:25636800	
Q7Z434	UniProtKB	Compositional bias	102	124	.	.	.	Note=Pro residues;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite	
Q7Z434	UniProtKB	Compositional bias	145	166	.	.	.	Note=Polar residues;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite	
Q7Z434	UniProtKB	Compositional bias	184	262	.	.	.	Note=Polar residues;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite	
Q7Z434	UniProtKB	Compositional bias	314	350	.	.	.	Note=Polar residues;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite	
Q7Z434	UniProtKB	Compositional bias	373	389	.	.	.	Note=Polar residues;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite	
Q7Z434	UniProtKB	Compositional bias	400	415	.	.	.	Note=Polar residues;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite	
Q7Z434	UniProtKB	Compositional bias	493	507	.	.	.	Note=Basic and acidic residues;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite	
Q7Z434	UniProtKB	Site	148	149	.	.	.	Note=(Microbial infection) Cleavage%3B by viral Seneca Valley virus protease 3C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28566380;Dbxref=PMID:28566380	
Q7Z434	UniProtKB	Site	148	148	.	.	.	Note=(Microbial infection) Cleavage by CV3B;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21436888;Dbxref=PMID:21436888	
Q7Z434	UniProtKB	Site	208	209	.	.	.	Note=(Microbial infection) Cleavage by protease 2A of enterovirus 71;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28253362;Dbxref=PMID:28253362	
Q7Z434	UniProtKB	Site	250	251	.	.	.	Note=(Microbial infection) Cleavage by protease 2A of enterovirus 71;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28253362;Dbxref=PMID:28253362	
Q7Z434	UniProtKB	Site	264	265	.	.	.	Note=(Microbial infection) Cleavage by protease 2A of enterovirus 71;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28253362;Dbxref=PMID:28253362	
Q7Z434	UniProtKB	Site	427	428	.	.	.	Note=(Microbial infection) Cleavage%3B by HAV protein 3ABC;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17438296;Dbxref=PMID:17438296	
Q7Z434	UniProtKB	Site	429	430	.	.	.	Note=Cleavage%3B by CASP3;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:30878284;Dbxref=PMID:30878284	
Q7Z434	UniProtKB	Site	490	491	.	.	.	Note=Cleavage%3B by CASP3;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:30878284;Dbxref=PMID:30878284	
Q7Z434	UniProtKB	Site	508	509	.	.	.	Note=(Microbial infection) Cleavage%3B by HCV and hepatitis GB virus B NS3/4A protease complex;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16177806,ECO:0000269|PubMed:16301520;Dbxref=PMID:16177806,PMID:16301520	
Q7Z434	UniProtKB	Modified residue	152	152	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0007744,ECO:0007744,ECO:0007744;evidence=ECO:0007744|PubMed:18669648,ECO:0007744|PubMed:19690332,ECO:0007744|PubMed:24275569;Dbxref=PMID:18669648,PMID:19690332,PMID:24275569	
Q7Z434	UniProtKB	Modified residue	157	157	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0007744;evidence=ECO:0007744|PubMed:18669648;Dbxref=PMID:18669648	
Q7Z434	UniProtKB	Modified residue	165	165	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0007744,ECO:0007744,ECO:0007744;evidence=ECO:0007744|PubMed:18669648,ECO:0007744|PubMed:19690332,ECO:0007744|PubMed:24275569;Dbxref=PMID:18669648,PMID:19690332,PMID:24275569	
Q7Z434	UniProtKB	Modified residue	180	180	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0007744;evidence=ECO:0007744|PubMed:24275569;Dbxref=PMID:24275569	
Q7Z434	UniProtKB	Modified residue	188	188	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0007744;evidence=ECO:0007744|PubMed:24275569;Dbxref=PMID:24275569	
Q7Z434	UniProtKB	Modified residue	215	215	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0007744;evidence=ECO:0007744|PubMed:24275569;Dbxref=PMID:24275569	
Q7Z434	UniProtKB	Modified residue	222	222	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0007744,ECO:0007744,ECO:0007744,ECO:0007744;evidence=ECO:0007744|PubMed:16964243,ECO:0007744|PubMed:18669648,ECO:0007744|PubMed:23186163,ECO:0007744|PubMed:24275569;Dbxref=PMID:16964243,PMID:18669648,PMID:23186163,PMID:24275569	
Q7Z434	UniProtKB	Modified residue	233	233	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0007744;evidence=ECO:0007744|PubMed:18669648;Dbxref=PMID:18669648	
Q7Z434	UniProtKB	Modified residue	234	234	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0007744;evidence=ECO:0007744|PubMed:18669648;Dbxref=PMID:18669648	
Q7Z434	UniProtKB	Modified residue	236	236	.	.	.	Note=Asymmetric dimethylarginine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q8VCF0	
Q7Z434	UniProtKB	Modified residue	253	253	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0007744;evidence=ECO:0007744|PubMed:20068231;Dbxref=PMID:20068231	
Q7Z434	UniProtKB	Modified residue	258	258	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0007744,ECO:0007744;evidence=ECO:0007744|PubMed:18669648,ECO:0007744|PubMed:20068231;Dbxref=PMID:18669648,PMID:20068231	
Q7Z434	UniProtKB	Modified residue	408	408	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q8VCF0	
Q7Z434	UniProtKB	Modified residue	442	442	.	.	.	Note=Phosphoserine%3B by TBK1;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:25636800,ECO:0000269|PubMed:27302953;Dbxref=PMID:25636800,PMID:27302953	
Q7Z434	UniProtKB	Alternative sequence	1	141	.	.	.	ID=VSP_045872;Note=In isoform 4. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
Q7Z434	UniProtKB	Alternative sequence	40	131	.	.	.	ID=VSP_047816;Note=In isoform 6. DRLRATCTLSGNRDTLWHLFNTLQRRPGWVEYFIAALRGCELVDLADEVASVYQSYQPRTSDRPPDPLEPPSLPAERPGPPTPAAAHSIPYN->GPRTVPQTHWSHRHFLLRGQGPPHLLRPTASPTTAAERRSQVTPCLSRRPRRQSPQERIQSKPCRRSAPEPSQGIQMVAPWSPPLTWQPSAL;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:18207245;Dbxref=PMID:18207245	
Q7Z434	UniProtKB	Alternative sequence	64	148	.	.	.	ID=VSP_010261;Note=In isoform 3. RRPGWVEYFIAALRGCELVDLADEVASVYQSYQPRTSDRPPDPLEPPSLPAERPGPPTPAAAHSIPYNSCREKEPSYPMPVQETQ->LPTWAGEETPGGQSSGRGLDFSSLTSGAVWLWQMSDFWSCFSTWTVSIWLILHWVLLRLNLQVFAKCLAQSKWPLLLPSLSCPTW;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
Q7Z434	UniProtKB	Alternative sequence	98	124	.	.	.	ID=VSP_047817;Note=In isoform 5. RTSDRPPDPLEPPSLPAERPGPPTPAA->QFRASPADAQPQSHPKESRWWPPGVLL;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:14702039,ECO:0000303|PubMed:18207245;Dbxref=PMID:14702039,PMID:18207245	
Q7Z434	UniProtKB	Alternative sequence	99	131	.	.	.	ID=VSP_010262;Note=In isoform 2. TSDRPPDPLEPPSLPAERPGPPTPAAAHSIPYN->ERPALALLDPQPAPWPPLSFSLSLYFLPFSVILFLVTVKR;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
Q7Z434	UniProtKB	Alternative sequence	125	540	.	.	.	ID=VSP_047818;Note=In isoform 5. Missing;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:14702039,ECO:0000303|PubMed:18207245;Dbxref=PMID:14702039,PMID:18207245	
Q7Z434	UniProtKB	Alternative sequence	132	540	.	.	.	ID=VSP_010263;Note=In isoform 2 and isoform 6. Missing;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:14702039,ECO:0000303|PubMed:18207245;Dbxref=PMID:14702039,PMID:18207245	
Q7Z434	UniProtKB	Alternative sequence	149	540	.	.	.	ID=VSP_010264;Note=In isoform 3. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
Q7Z434	UniProtKB	Natural variant	79	79	.	.	.	ID=VAR_048609;Note=C->F;Dbxref=dbSNP:rs11905552	
Q7Z434	UniProtKB	Natural variant	79	79	.	.	.	ID=VAR_059197;Note=C->S;Dbxref=dbSNP:rs11908032	
Q7Z434	UniProtKB	Natural variant	93	93	.	.	.	ID=VAR_048610;Note=Q->E;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14702039,ECO:0000269|PubMed:15489334,ECO:0000269|PubMed:16127453,ECO:0000269|PubMed:16153868;Dbxref=dbSNP:rs17857295,PMID:14702039,PMID:15489334,PMID:16127453,PMID:16153868	
Q7Z434	UniProtKB	Natural variant	198	198	.	.	.	ID=VAR_048611;Note=Q->K;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15489334,ECO:0000269|PubMed:16125763,ECO:0000269|PubMed:16177806;Dbxref=dbSNP:rs7262903,PMID:15489334,PMID:16125763,PMID:16177806	
Q7Z434	UniProtKB	Natural variant	409	409	.	.	.	ID=VAR_018448;Note=S->F;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15489334,ECO:0000269|PubMed:16125763,ECO:0000269|PubMed:16177806;Dbxref=dbSNP:rs7269320,PMID:15489334,PMID:16125763,PMID:16177806	
Q7Z434	UniProtKB	Mutagenesis	26	26	.	.	.	Note=Impairs filament formation and abolishes antiviral signaling activity. E->A%2CR;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24569476;Dbxref=PMID:24569476	
Q7Z434	UniProtKB	Mutagenesis	54	54	.	.	.	Note=Impairs ability to induce IFN-beta. Loss of interaction with the ATG5-ATG12 conjugate. T->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16125763,ECO:0000269|PubMed:17709747;Dbxref=PMID:16125763,PMID:17709747	
Q7Z434	UniProtKB	Mutagenesis	56	56	.	.	.	Note=Impairs filament formation and abolishes antiviral signaling activity. W->A%2CE%2CR;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24569476;Dbxref=PMID:24569476	
Q7Z434	UniProtKB	Mutagenesis	67	69	.	.	.	Note=Impairs ability to induce IFN-beta. GWV->AAA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16125763;Dbxref=PMID:16125763	
Q7Z434	UniProtKB	Mutagenesis	145	145	.	.	.	Note=No interaction with TRAF2. Q->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16153868;Dbxref=PMID:16153868	
Q7Z434	UniProtKB	Mutagenesis	148	148	.	.	.	Note=Complete loss of cleavage by Seneca Valley virus protease 3C. Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28566380;Dbxref=PMID:28566380	
Q7Z434	UniProtKB	Mutagenesis	155	155	.	.	.	Note=No interaction with TRAF6%3B when associated with D-457. E->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16153868;Dbxref=PMID:16153868	
Q7Z434	UniProtKB	Mutagenesis	159	159	.	.	.	Note=No effect on cleavage by Seneca Valley virus protease 3C. Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28566380;Dbxref=PMID:28566380	
Q7Z434	UniProtKB	Mutagenesis	162	162	.	.	.	Note=No effect on cleavage by Seneca Valley virus protease 3C. Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28566380;Dbxref=PMID:28566380	
Q7Z434	UniProtKB	Mutagenesis	196	196	.	.	.	Note=No effect on cleavage by Seneca Valley virus protease 3C. Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28566380;Dbxref=PMID:28566380	
Q7Z434	UniProtKB	Mutagenesis	198	198	.	.	.	Note=No effect on cleavage by Seneca Valley virus protease 3C. Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28566380;Dbxref=PMID:28566380	
Q7Z434	UniProtKB	Mutagenesis	209	209	.	.	.	Note=Complete loss of cleavage by protease 2A of enterovirus 71. G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28253362;Dbxref=PMID:28253362	
Q7Z434	UniProtKB	Mutagenesis	251	251	.	.	.	Note=Complete loss of cleavage by protease 2A of enterovirus 71. G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28253362;Dbxref=PMID:28253362	
Q7Z434	UniProtKB	Mutagenesis	265	265	.	.	.	Note=Complete loss of cleavage by enterovirus 71. G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28253362;Dbxref=PMID:28253362	
Q7Z434	UniProtKB	Mutagenesis	427	427	.	.	.	Note=No cleavage by HHAV 3ABC. Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17438296;Dbxref=PMID:17438296	
Q7Z434	UniProtKB	Mutagenesis	429	429	.	.	.	Note=Decreased cleavage by CASP3. Abolished cleavage by CASP3%3B when associated with A-490. D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:30878284;Dbxref=PMID:30878284	
Q7Z434	UniProtKB	Mutagenesis	435	435	.	.	.	Note=No effect on cleavage by NS3/4A protease complex. C->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16301520;Dbxref=PMID:16301520	
Q7Z434	UniProtKB	Mutagenesis	442	442	.	.	.	Note=Abolished ability to bind and activate IRF3. S->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:25636800,ECO:0000269|PubMed:27302953;Dbxref=PMID:25636800,PMID:27302953	
Q7Z434	UniProtKB	Mutagenesis	452	452	.	.	.	Note=No effect on cleavage by NS3/4A protease complex. C->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16301520;Dbxref=PMID:16301520	
Q7Z434	UniProtKB	Mutagenesis	457	457	.	.	.	Note=No interaction with TRAF6%3B when associated with D-155. E->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16153868;Dbxref=PMID:16153868	
Q7Z434	UniProtKB	Mutagenesis	463	463	.	.	.	Note=No effect on cleavage by HHAV 3ABC. E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17438296;Dbxref=PMID:17438296	
Q7Z434	UniProtKB	Mutagenesis	490	490	.	.	.	Note=Decreased cleavage by CASP3. Abolished cleavage by CASP3%3B when associated with A-429. D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:30878284;Dbxref=PMID:30878284	
Q7Z434	UniProtKB	Mutagenesis	508	508	.	.	.	Note=No cleavage by HCV and hepatitis GB virus B NS3/4A protease complex. C->A%2CR;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16177806,ECO:0000269|PubMed:16301520,ECO:0000269|PubMed:17093192;Dbxref=PMID:16177806,PMID:16301520,PMID:17093192	
Q7Z434	UniProtKB	Sequence conflict	42	42	.	.	.	Note=L->P;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q7Z434	UniProtKB	Sequence conflict	191	191	.	.	.	Note=T->N;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q7Z434	UniProtKB	Sequence conflict	356	356	.	.	.	Note=A->V;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q7Z434	UniProtKB	Sequence conflict	373	373	.	.	.	Note=S->P;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q7Z434	UniProtKB	Helix	3	14	.	.	.	Ontology_term=ECO:0007829;evidence=ECO:0007829|PDB:2VGQ	
Q7Z434	UniProtKB	Helix	16	19	.	.	.	Ontology_term=ECO:0007829;evidence=ECO:0007829|PDB:2VGQ	
Q7Z434	UniProtKB	Helix	24	27	.	.	.	Ontology_term=ECO:0007829;evidence=ECO:0007829|PDB:2VGQ	
Q7Z434	UniProtKB	Helix	28	30	.	.	.	Ontology_term=ECO:0007829;evidence=ECO:0007829|PDB:2VGQ	
Q7Z434	UniProtKB	Helix	36	49	.	.	.	Ontology_term=ECO:0007829;evidence=ECO:0007829|PDB:2VGQ	
Q7Z434	UniProtKB	Helix	51	62	.	.	.	Ontology_term=ECO:0007829;evidence=ECO:0007829|PDB:2VGQ	
Q7Z434	UniProtKB	Helix	68	78	.	.	.	Ontology_term=ECO:0007829;evidence=ECO:0007829|PDB:2VGQ	
Q7Z434	UniProtKB	Helix	82	92	.	.	.	Ontology_term=ECO:0007829;evidence=ECO:0007829|PDB:2VGQ	
Q7Z434	UniProtKB	Beta strand	95	97	.	.	.	Ontology_term=ECO:0007829;evidence=ECO:0007829|PDB:2MS8	
Q7Z434	UniProtKB	Beta strand	456	459	.	.	.	Ontology_term=ECO:0007829;evidence=ECO:0007829|PDB:4Z8M	
Q7Z434	UniProtKB	Beta strand	504	507	.	.	.	Ontology_term=ECO:0007829;evidence=ECO:0007829|PDB:3RC5	
